This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
Genomic Biomarker Testing
PEACE-3 Trial
PROfound Trial
PSMAfore Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
BOND-003 Cohort P
CORE-001 Study
CORE-008
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Daniel D. Joyce, MD, MS
Bladder Cancer
Non-Muscle Invasive Bladder Cancer
Ashish Kamat, MD
Muscle-Invasive Bladder Cancer
Advanced & Metastatic Bladder Cancer (mUC)
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher® Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
mCRPC with Bone Metastasis
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
Testicular, Penile & Rare GU Malignances
Testicular Cancer
Functional Urology
Functional Urology
Alan J. Wein, MD, PhD (hon.)
Urologic Catheters - CAUTI Challenges
Videos
Exclusives
Conferences
Disparities: Social Determinants of Health
Exclusive Collaborations
Health Policy in Urological Diseases
Independent Medical Education
Journal Clubs
Practice Guidelines Reviews
The Prostate Cancer Foundation
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Functional Urology
Men's Health
Pelvic Health
Actionable Clinical Data
Bladder Cancer
NMIBC with CIS: Evidence, Practice & Emerging Research
Risk-Stratified NMIBC Management
Trials in Progress
Prostate Cancer
Localized Prostate Cancer
CLARIFY
ESCAPE
FORT
NRG-GU 0101
RTIRE
High Risk BCR HSPC
ARASTEP
Oligometastatic Prostate Cancer
METANOVA
mHSPC
ARASEC
ASPIRE
MEVPRO-3
mCRPC
ECLIPSE
LEGION-100
MEVPRO-1 & 2
PROMISE
SECuRE
Bladder Cancer
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SNMMI 2026
ASCO 2026
AUA 2026
APCCC 2026
PSMA and Beyond 2026
All Conferences
View All
PCF
UroToday Home
Conference Highlights
AUA 2019
AUA 2019
Prostate Cancer
Bladder Cancer
Renal Cancer
Testis & Penile Cancers
Lower Urinary Tract Conditions
GU Reconstruction
Infections & Inflammation
Laparoscopic / Robotic Surgery
Sexual Function
Stone Disease
Press Releases
AUA 2019 Renal Cancer
Viewing 1-20 of 39 articles
AUA 2019: The Role of Cytoreductive Radical Therapy in the Era of Targeted Therapy for Metastatic RCC
AUA 2019: Understanding the Effectiveness of Lymphadenectomy in Node Only Recurrences after Nephrectomy for Kidney Cancer
AUA 2019: Machine Learning to Predict Recurrence of Localized Renal Cell Carcinoma
AUA 2019: Journal of Urology Lecture: Evolving Strategies in the Management of Small Renal Masses
AUA 2019: Phase III Trial of Intravenous Mannitol Versus Placebo During Nephron Sparing Surgery: 3-Year Outcomes
AUA 2019: Multiparametric Magnetic Resonance Imaging Identifies Clear Cell Renal Cell Carcinoma with Greater Accuracy in Higher Stage Lesions
AUA 2019: Office-Based, Ultrasound-Guided Renal Mass Biopsy: Technique and Results
AUA 2019: Early Recurrence Patterns Should Inform Surveillance Protocols Following Surgery for High Risk Non-Metastatic Renal Cell Carcinoma
AUA 2019: Comprehensive Characterization of Circulating Tumor DNA in Plasma and Urine of Patients with Renal Tumors: Results of the DIAMOND and MonReC Studies
AUA 2019: CT-Based Shape and Texture Metrics Independently Discriminate Benign from Malignant Renal Masses
AUA 2019: Derivation and Validation of Text Search Algorithms for Renal and Adrenal Lesion Identification in Radiology Text Reports
AUA 2019: Improved Detection of Indeterminate Renal Mass Vascularity with Superb Microvascular Imaging
AUA 2019: Renal Hypothermia During Partial Nephrectomy: A Randomized Controlled Trial
AUA 2019: Renal Mass Biopsy vs. Biopsy of Masses in Other Organs: Why Is It Different Only for the Kidney?
AUA 2019: Oncological Effectiveness of Image Guided Thermal Ablation for Recurrent Renal Cell Carcinoma after Ipsilateral Partial Nephrectomy: Tertiary Cancer Center Experience
AUA 2019: Development and Validation of a Risk Score Based on Patient Characteristics to Predict Major Complications after Partial Nephrectomy
AUA 2019: Comparison of Perioperative and Oncologic Outcomes between Cryoablation and Partial Nephrectomy for Small Renal masses: A Propensity-Score Matching Analysis
AUA 2019: Predicting Functional Outcomes after Partial Nephrectomy
AUA 2019: Impact of Implementation of Standardized Criteria in the Assessment of Complication Reporting after Robotic Partial Nephrectomy
AUA 2019: Crossfire: Controversies in Urology: Radical Nephrectomy for T1b/T2 Renal Cancer
1
2
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free